(0.21%) 5 142.25 points
(0.18%) 38 509 points
(0.29%) 17 897 points
(-1.00%) $83.01
(1.66%) $1.955
(-0.17%) $2 343.20
(0.89%) $27.50
(0.25%) $924.40
(-0.21%) $0.933
(-0.19%) $11.00
(-0.27%) $0.798
(1.21%) $92.99
Live Chart Being Loaded With Signals
Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders...
Stats | |
---|---|
今日成交量 | 142 127 |
平均成交量 | 713 549 |
市值 | 9.16M |
EPS | SEK0 ( 2024-02-23 ) |
下一个收益日期 | ( SEK0 ) 2024-05-10 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -0.220 |
ATR14 | SEK0.00200 (2.15%) |
Cyxone AB (publ) 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Cyxone AB (publ) 财务报表
Annual | 2023 |
营收: | SEK0 |
毛利润: | SEK-2.54M (0.00 %) |
EPS: | SEK-0.220 |
FY | 2023 |
营收: | SEK0 |
毛利润: | SEK-2.54M (0.00 %) |
EPS: | SEK-0.220 |
FY | 2022 |
营收: | SEK6.40M |
毛利润: | SEK4.16M (64.98 %) |
EPS: | SEK-0.430 |
FY | 2021 |
营收: | SEK0.00 |
毛利润: | SEK0.00 (0.00 %) |
EPS: | SEK-0.429 |
Financial Reports:
No articles found.
Cyxone AB (publ)
Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders. Its development portfolio comprises Rabeximod in a clinical Phase II program for rheumatoid arthritis and Covid-19 infections; and T20K, a Phase 1 candidate drug for the treatment of multiple sclerosis. The company was incorporated in 2015 and is based in Malmö, Sweden.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。